XML 77 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity (Tables)
12 Months Ended
Dec. 31, 2012
Stockholders' Equity Note [Abstract]  
Schedule of Change in Preferred and Common Shares Issued and Common Shares Held as Treasury Shares
The following table shows the change in Preferred and Common Stock issued and common shares held as treasury shares for the three years ended December 31, 2012.
 
 
(shares in thousands)
Preferred
Stock
Issued
 
Common
Stock
Issued
 
Treasury
Stock
Held
Balance at December 31, 2009
968

 
495,514

 
5,686

Issuance (forfeitures) of non-vested stock, net

 
(9
)
 

Restricted share unit activity

 
44

 

Stock options exercised

 
1

 

Treasury shares purchased

 

 
7

Issuance of common stock

 
293,250

 

  Settlement of prepaid common stock purchase
   contracts    

 
2,156

 

Balance at December 31, 2010
968

 
790,956

 
5,693

Issuance (forfeitures) of non-vested stock, net

 
(1
)
 

Restricted share unit activity

 
19

 

Settlement of prepaid common stock purchase contracts

 
15

 

Balance at December 31, 2011
968

 
790,989

 
5,693

Restricted share unit activity

 
1,284

 

Balance at December 31, 2012
968

 
792,273

 
5,693

 
 
 
 
 
 
Schedule of Aggregate Values Assigned to Each Component of tMEDS Offering
The aggregate values assigned to each component of the tMEDS offering are as follows:
(in thousands, except per unit amounts)
 
Equity Component
 
Debt Component
 
tMEDS
Total
Units issued (1)    
 
13,800

 
13,800

 
13,800

Unit price
 
$
19.901803

 
5.098197

 
25.00

Gross proceeds
 
274,645

 
70,355

 
345,000

Issuance costs
 
9,081

 
2,342

 
11,423

Net proceeds
 
$
265,564

 
68,013

 
333,577

 
 
 
 
 
 
 
Impact on Consolidated Balance Sheet:
 
 
 
 
 
 
Other assets (prepaid issuance costs)
 
$

 
2,342

 
2,342

Long-term debt
 

 
70,355

 
70,355

Additional paid-in capital
 
265,564

 

 
265,564

 
 
 
 
 
 
 

(1) 
There are two components of each tMEDS unit; therefore, there are 13.8 million units of the equity component, 13.8 million units of the debt component, and 13.8 million units of tMEDS, which includes both the debt and equity components.
Schedule of Weighted of the Volume Average Price of Common Stock
Applicable Market Value of Synovus Common Stock
 
Settlement Rate
Less than or equal to $2.75
 
9.0909
Between $2.75 and $3.30
 
Number of shares equal to $25, divided by the applicable market price
Greater than or equal to $3.30
 
7.5758
Schedule of Accumulated Other Comprehensive Income (Loss)
Activity within the balances in accumulated other comprehensive income (loss) is shown in the following table for the three years ended December 31, 2012.
(in thousands)
Unrealized gains (losses) on cash flow hedges
 
Unrealized gains (losses) on investment securities available for sale
 
Post-retirement unfunded health benefit
 
Accumulated other comprehensive income (loss)
2010
 
 
 
 
 
 
 
Beginning of year
$
19,242

 
67,084

 
(1,520
)
 
84,806

Period change, net of tax*
(20,450
)
 
(8,718
)
 
1,520

 
(27,648
)
Balance at December 31, 2010
(1,208
)
 
58,366

 

 
57,158

2011
 
 
 
 
 
 
 
Beginning of year
(1,208
)
 
58,366

 

 
57,158

Period change, net of tax*
(11,316
)
 
(24,749
)
 

 
(36,065
)
Balance at December 31, 2011
(12,524
)
 
33,617

 

 
21,093

2012
 
 
 
 
 
 
 
Beginning of year
(12,524
)
 
33,617

 

 
21,093

Period change, net of tax
(849
)
 
(16,506
)
 
363

 
(16,992
)
Balance at December 31, 2012
$
(13,373
)
 
17,111

 
363

 
4,101


 
 
 
 
 
 
 
*In accordance with ASC 740-20-45-11(b), the deferred tax asset valuation allowance associated with unrealized gains and losses not recognized in income is charged directly to other comprehensive income (loss).